Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-18

Study Completion Date

2029-07-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their levels, the way these particles function plays a key role in preventing or contributing to disease. In some conditions, like high cholesterol or diabetes, lipoproteins may not work properly, increasing the risk of clogged arteries and other complications.

The investigators aim to study these changes in people with lipid disorders to better understand their impact on blood health and to find new ways to prevent and treat heart disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Causes and Natural History of Dyslipidemias

NCT00353782

Hypercholesterolemia Atherosclerosis

RECRUITING

Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and Women

NCT00037258

Cardiovascular Diseases Diabetes Mellitus, Non-insulin Dependent Heart Diseases +2 more

COMPLETED

Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Identified Through Family Screening

NCT06995183

Lipoprotein(a)

RECRUITING

Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia

NCT00005313

Atherosclerosis Cardiovascular Diseases Heart Diseases +2 more

COMPLETED

Physiological Effects of ANGPTL3 Variants in Humans

NCT04234724

Hypocholesterolemia

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Traditionally, lipoproteins have been associated with cardiovascular protection, but emerging research indicates that their functionality may be a more critical factor than their levels in evaluating cardiovascular risk. Lipoproteins, such as HDL, LDL, and VLDL, play vital roles in processes like reverse cholesterol transport and demonstrate anti-inflammatory, antioxidative, and antiplatelet properties. However, in conditions like atherosclerosis, diabetes, and dyslipidemia, these lipoproteins often become dysfunctional, and the mechanisms behind this dysfunction remain incompletely understood.

This study aims to thoroughly investigate the pathogenic roles of lipoproteins by examining their structural and functional modifications and their influence on platelet activity in individuals with lipid disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lipid Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Individuals with lipid disorders

Individuals with lipid disorders (elevated HDL and LDL)

No interventions assigned to this group

Healthy individuals

Healthy individuals with normal lipid values and without lipid-related diseases

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers
* Abnormalities in lipid panels
* Able to provide informed consent
* Between the age of 18 and 69

Exclusion Criteria

* Drug or alcohol abuse within 6 months or significant mental/psychological impairment
* Current smokers
* Subjects with known bleeding disorders (for example, hemophilia)
* Subjects requiring regular transfusions for any reason
* No ethnic/racial groups will be excluded

Minimum Eligible Age

18 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes